Serum CXCL1 concentrations were significantly higher in CRC patients in comparison to healthy controls (p = 0.034), and were similar to those of the well-established biomarker CEA (p < 0.001) and the indicator of inflammation CRP (p < 0.001) (Figure 1). This evidence concerns the gene CXCL1 and colorectal carcinoma.